Loading company…
Puheng Technology develops humanized in vitro 3D models, products, and services for drug development.
Founded in 2021 and based in Shanghai, China, Puheng Technology develops drug development systems based on humanized in vitro 3D models. Its NAC-organ technology supports 3D models, reagent consumables, and testing services for drug safety, chronic disease, cancer, and delivery systems. In January 2024, Pudong Venture Capital made a strategic investment. The company planned to develop and commercialize its technology and platforms.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in